Allan T. Bombard, M.D.

Allan T. Bombard, M.D. is chief medical officer, Sequenom, Inc. as well as clinical professor, obstetrics and gynecology, Albert Einstein College of Medicine.

Prior to joining Sequenom, Dr. Bombard was chief executive officer, Lenetix Medical Screening Laboratories, Inc. in Mineola, New York, where he transitioned from his role as chief medical Officer, Sharp Mary Birch Hospital in San Diego, CA. Before joining Sharp Healthcare Dr. Bombard was senior vice president, chair and residency program director, department of Ob/Gyn at Lutheran Medical Center, Brooklyn, NY. Dr. Bombard came to Lutheran Medical Center from Aetna, Inc., where he served as the Western U.S. medical director for women’s health. Before working for Aetna, he served as professor & director, reproductive genetics, department of Ob/Gyn & women’s health at Montefiore Medical Center and the Albert Einstein College of Medicine in Bronx, New York. He attained the academic rank of professor at the medical school in 1997.

Dr. Bombard received his Bachelor of Arts degree from Colgate University, his Doctor of Medicine degree from the George Washington University, and his Masters in Business Administration from the University of San Diego. He completed a residency in Ob/Gyn at the Wilford Hall USAF Medical Center in San Antonio, Texas, and his fellowship in Clinical Genetics at Northwestern University in Chicago, Illinois. Dr. Bombard is board certified in both Clinical Genetics as well as Obstetrics & Gynecology.

Dr. Bombard retired from the USAF Reserves in 2002 with the rank of Colonel and served in Operation Desert Storm. He is a Founding Fellow of the American College of Medical Genetics, a Fellow of the American College of Obstetricians & Gynecologists, a member of the American Medical Association, and a life member of the American College of Physician Executives. He serves on a number of national professional committees and has lectured extensively on a variety of women’s health issues including genetic counseling, prenatal screening & diagnosis, the business of medicine, and BRCA screening. His articles have appeared in peer-reviewed medical journals such as the Lancet and the American Journal of Obstetrics & Gynecology.


Frank A. Chervenak, M.D.

Frank A. Chervenak, M.D. currently serves as the Given Foundation Professor and Chairman of the Department of Obstetrics and Gynecology, as well as Obstetrician and Gynecologist-in-Chief and the Director of Maternal Fetal Medicine at the New York Presbyterian Hospital, Weill Medical College of Cornell University. He received his Bachelor of Science degree from Pennsylvania State University with highest distinction, and his medical degree from Thomas Jefferson University where he was elected a member of Alpha Omega Alpha Medical Honor Society. Dr. Chervenak served his internship in Internal Medicine at New York Medical College, residency in Obstetrics and Gynecology at New York Medical College in St. Luke’s Roosevelt Hospital Center, and a fellowship in Maternal Fetal Medicine at Yale University School of Medicine. He was Assistant Professor of Obstetrics and Gynecology at Mt. Sinai Medical Center, where he was also Director of Perinatal Research and received the Dr. Solomon Silver Award for application of advances in research to the practice of Clinical Medicine.

Dr. Chervenak was appointed Associate Professor of Obstetrics and Gynecology and Director of Obstetric Ultrasound and Ethics at New York Hospital-Cornell Medical Center in 1987. In 1991 he was named Director of Maternal Fetal Medicine and Director of Obstetrics. In 1992 he was made Full Professor with tenure, in 1998 he was named Vice Chairman of the Department of Obstetrics and Gynecology, and in 1999 was named Acting Chairman of that department. Dr. Chervenak was named Chairman and Obstetrician and Gynecologist-in-Chief in 2000. He received his Master in Medical Management degree from Carnegie Mellon University in 2002 and earned fellowship status from the American College of Physician Executives in 2008.

Dr. Chervenak has published over 230 papers in peer review literature and has co-authored or co-edited 27 textbooks. Research interests include ultrasound and ethics in obstetrics & gynecology and physician leadership. Dr. Chervenak has served on the Board of Governors of the American Institute in Ultrasound and Medicine and the Society of Perinatal Obstetricians. He has served as President of the International Fetal Medicine in Surgery Society, the New York Perinatal Society and the New York Academy of Medicine Section of Obstetrics and Gynecology, and the New York Obstetrical Society. Currently, Dr. Chervenak serves as President of the International Society of the Fetus as a Patient, President of the World Association of Perinatal Medicine, Vice-president of the International Academy of Perinatal Medicine, and Co-director of The Ian Donald Inter-University School of Medicine and Ultrasound. He serves on the March of Dimes Bioethics Committee and Prematurity Research Advisory Committee.

He has been awarded honorary doctorates from Semmelweis University in Budapest, Hungary, and the University of Athens, Greece. He is an honorary member of the Italian Society of Obstetrics and Gynecology, Barcelona Society of Obstetrics and Gynecology, Romanian Obstetric and Gynecologic Society, Hungarian Ultrasound Society, and the Texas Society of Obstetrics and Gynecology, and a Corresponding Member of the Academy of Medical Science of Croatia.


Arnold W. Cohen, M.D.

Arnold W. Cohen, M.D. trained in Ob/Gyn and MFM at the Hospital of the University of Pennsylvania. He has been Chairman, Division of Maternal-Fetal Medicine at Albert Einstein Medical Center, Director of Obstetrics and Maternal- Fetal Medicine at the Hospital of the University of Pennsylvania and now Chairman of Ob/Gyn at Albert Einstein Medical Center. He has been a Professor of Ob/Gyn at both Jefferson Medical College and University of Pennsylvania. His major academic interests have been in the management of high risk pregnant patients with medical complications of pregnancy. He has published over 100 original articles, chapters and abstracts related to Obstetric care.

In 1993 he became Corporate Medical Director of Women's Health at U.S. Healthcare and then Aetna responsible for the development and implementation of all Women's Health Care programs for 18.5 million members.

He has served as the President of many local and national Perinatal and Ob Associations and committees including the Philadelphia Perinatal Society and the Pennsylvania Section of ACOG. He has been the chairman of ACOG’s Committee on Course Coordination, a Board Member of the Society for Maternal Fetal Medicine, member of the Coding and Government Relations committee and Chair of the Medical Liability Committee. He is the Past President of the Obstetrical Society of Philadelphia and the Philadelphia Perinatal Society. He chairs a subcommittee for the Commissioner of Health on the impact of Obstetrical Care Unit Closures on the Quality of Care patients receive in Philadelphia. He is the Chairman of the National Advisory Committee of the Victor Centers for Jewish Genetic Diseases and now serves on the Clinical Advisory Board of Sequenom.


Dr. Michal Elovitz

Michal A. Elovitz, M.D. is an Associate Professor at the University of Pennsylvania. She has served as Director of the Maternal and Child Health Research Program at the University of Pennsylvania since 2009. In addition, she has been the Director of the Maternal Fetal Medicine Fellowship since 2006 and runs the Prematurity Prevention Program at the University of Pennsylvania.

Dr. Elovitz received her medical degree from the Albert Einstein College of Medicine in New York. She successfully completed a Residency in Obstetrics and Gynecology at Cornell University then completed a three year Maternal Fetal Medicine Fellowship at the University of Chicago. During her fellowship, Dr. Elovitz was awarded her first grant investigating causes of prematurity. After completing her fellowship, she was began her career at the University of Pennsylvania as a Women's Reproductive Health Research scholar. Since first joining the faculty, Dr. Elovitz's research program has flourished. Dr. Elovitz directs a productive translational and clinical research program focused on major complications of pregnancy including prematurity and preeclampsia. Dr. Elovitz has been funded by the National Institutes of Health, the March of Dimes, the Burroughs Welcome Fund and the Preeclampsia Foundation.


Wolfgang Holzgreve, M.D.

Dr. Holzgreve graduated from the School of Medicine, the Westfälische Wilhelm University, Münster, Germany in 1975. In 1976, he earned the degree of Master of Science in Health and Medical Sciences at the University of California, Berkeley. From 1976 to 1978, he studied at the School of Medicine in Münster, Germany, and finished his residency in Obstetrics and Gynecology, Department of Obstetrics and Gynecology, University of Münster, in 1982. Between 1982 and 1984, he completed a Fellowship of the German Research Foundation in Reproductive Genetics, at the Department of Obstetrics and Gynecology and Reproductive Sciences at the University of California, San Francisco, USA. Dr. Holzgreve was Board Certified in Clinical Genetics and Obstetrics and Gynecology in 1985.

By 1991, he had risen to the rank of Professor of Obstetrics and Gynecology, Geschäftsf. Oberarzt, Department of Obstetrics and Gynecology, University of Münster. In August 1995, he moved to Switzerland to take up his present appointment as Chairman of the Department and Chief of Service at the Department of Obstetrics and Gynecology, University of Basel, from where he transitioned to his current position in Freiburg in 2009.

His publications have numbered more than 500 articles in important peer-reviewed scientific journals, 180 book chapters, 6 books, 400 abstracts at scientific meetings, and more than 400 oral presentations at postgraduate courses and seminars. Dr. Holzgreve is on the editorial board of many important journals and is a reviewer for the New England Journal of Medicine, the American Journal of Obstetrics and Gynecology, Obstetrics and Gynecology, Journal of Pediatrics, Prenatal Diagnosis, Human Genetics, Journal of Ultrasound in Obstetrics & Gynecology, American Journal of Medical Genetics, Schweizerische Medizinische Wochenschrift, Gene, and Human Reproduction. Dr. Holzgreve has also received numerous prize and awards. Dr. Holzgreve is also currently the President of the International Society "The Fetus as a Patient", the German Society of Reproductive Medicine, and the Chairman of the Scientific Committee of the World Federation of Perinatal Medicine.


Dennis Lo, DM DPhil

Dennis Lo, DM DPhil is the Li Ka Shing Professor of Medicine  and Professor of Chemical Pathology of the Chinese University of Hong Kong. He received his BA from the University of Cambridge and his DM and DPhil degrees from the University of Oxford. He discovered the presence of cell-free fetal DNA in maternal plasma in 1997. 
Since then he has been exploring the biology and diagnostic applications of this phenomenon, and has successfully developed applications of this technology for the prenatal diagnosis of fetal RhD status, monogenic diseases and fetal chromosomal aneuploidies. He serves on the Board in his capacity as a consultant to Sequenom.


Lee P. Shulman, M.D. FACMG FACOG

Lee P. Shulman M.D. is the Anna Ross Lapham Professor in Obstetrics and Gynecology and Chief of the Division of Reproductive at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. He also serves as the Co-Director of the Northwestern Ovarian Cancer Early Detection and Prevention Program and is the Medical Director of the Graduate Program in Genetic Counseling at Northwestern University. He is a Fellow of the American College of Obstetricians and Gynecologists and a Founding Fellow of the American College of Medical Genetics.

Dr. Shulman was graduated from Cornell University in 1979 with a BA degree in the College Scholar program. He then attended Cornell University Medical College where he received his Doctor of Medicine degree in 1983. Dr. Shulman completed an internship and residency in Obstetrics and Gynecology at North Shore University Hospital – Cornell University Medical College in 1987 and served as Chief Resident during his final year. From there he completed a fellowship in Reproductive Genetics at the University of Tennessee, Memphis and then joined the Ob/Gyn faculty of the University of Tennessee, Memphis, becoming the Director of Reproductive Genetics in 1994. In 1999 he relocated to the University of Illinois at Chicago where he served as Deputy Head of the Department of Obstetrics and Gynecology, Director of the Divisions of Reproductive Genetics and Ambulatory Care Services and as Medical Director of the Center of Excellence in Women’s Health.

Dr. Shulman is a member of numerous regional, national and international organizations that pertain to the health and care of women. He currently serves as the Immediate Past Chair of the Board of Trustees of the Association of Reproductive Health Professionals. His work has been recognized regionally and nationally; most recently, he was included in the list of “Top Doctors” in Chicago (2007-8) and the United States. He is the Editor-in-Chief of the Yearbook of Obstetrics and Gynecology and Reproductive Medicine, is a Contributing Editor for The Journal of Reproductive Medicine and the Executive Editor of the Journal of Gynecologic Surgery. He also serves on the editorial boards of Prenatal Diagnosis, Journal of Pediatric and Adolescent Gynecology, Contraception, Menopause, and as a peer-reviewer for 31 journals. A frequent contributor to the peer-reviewed and informational literature with over 130 peer-reviewed articles and over 50 book chapters, Dr. Shulman serves on governmental, foundation and pharmaceutical advisory boards and is currently a member of the Medical Advisory Board for the Chicago Center for Jewish Genetic Diseases and on the Board of Trustees of the Society for Family Planning. His major research interests are in reproductive genetics, contraception, botanical interventions in women’s health and menopause.


Yves Ville, M.D.

Yves Ville, M.D. currently serves as Professor and Chairman of the Department of Obstetrics and Fetal Medicine at Necker-Enfants-Malades Hospital, Paris Descartes University. He received his medical degree from Paris University in 1986. Dr. Ville served his internship and Residency in Surgery and in Obstetrics and Gynecology in Paris teaching Hospitals and at the Harris Birthright Research Centre, King’s College Hospital in London. He served as a Volunteer Obstetrician in Gabon, at Franceville Hospital and International Research Centre for 18 months in 1988. He was Assistant Professor of Obstetrics and Gynecology at Antoine Béclère Hospital and Paris University between 1993 and 1996.

Dr. Ville was appointed Consultant and Senior Lecturer in Obstetrics and Gynecology and Director of the Fetal Medicine Unit at St Georges’ Hospital and Medical School in London in 1996.  In 1998 he was made Full Professor and Chairman of the Department of Obstetrics and Gynecology in Poissy Hospital and Paris-Ouest University. In 2008 he became Chairman of the department of Obstetrics and Fetal Medicine at Necker-Enfants-Malades Hospital, Paris Descartes University.

Dr. Ville has published over 320 papers in peer review literature and has co-authored or co-edited 10 textbooks. Research interests include Prenatal Diagnosis, Fetal Medicine and Surgery, and ultrasound in obstetrics. 

Dr. Ville serves on the council of the National Agency for Biomedicine as well as on the National Screening Committee in Prenatal Ultrasound. He serves as Associate-Dean for International Affairs at Paris-Descartes Medical School. He is the Director of a Master Degree in Prenatal Diagnosis and Fetal Medicine. He serves as Editor-in-Chief of Ultrasound in Obstetrics and Gynecology.  He serves as General Secretary of the European Association of Perinatal Medicine, Board Member of the International Society of Ultrasound in Obstetrics and Gynecology. He is a member of the International Academy of Perinatal Medicine.